1. Home
  2. QUBT vs BCRX Comparison

QUBT vs BCRX Comparison

Compare QUBT & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quantum Computing Inc.

QUBT

Quantum Computing Inc.

N/A

Current Price

$4.45

Market Cap

1.7B

Sector

Technology

ML Signal

N/A

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

N/A

Current Price

$7.20

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
QUBT
BCRX
Founded
2001
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Manufacturing
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.0B
IPO Year
2019
1995

Fundamental Metrics

Financial Performance
Metric
QUBT
BCRX
Price
$4.45
$7.20
Analyst Decision
Buy
Buy
Analyst Count
6
11
Target Price
$18.00
★ $20.45
AVG Volume (30 Days)
★ 6.5M
4.5M
Earning Date
11-09-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
84.93
★ 381.40
EPS
★ N/A
N/A
Revenue
$682,000.00
★ $25,186,000.00
Revenue This Year
$4,162.11
N/A
Revenue Next Year
$80.99
$3.71
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 82.84
N/A
52 Week Low
$4.86
$6.23
52 Week High
$14.45
$11.22

Technical Indicators

Market Signals
Indicator
QUBT
BCRX
Relative Strength Index (RSI) 26.69 35.29
Support Level N/A N/A
Resistance Level $9.38 $8.83
Average True Range (ATR) 0.49 0.37
MACD -0.13 -0.05
Stochastic Oscillator 0.95 0.87

Price Performance

Historical Comparison
QUBT
BCRX

About QUBT Quantum Computing Inc.

Quantum Computing Inc is an integrated photonics and non-linear quantum optics company to develop and deliver machines for quantum computing, reservoir computing, and remote sensing, imaging, and cybersecurity applications based on patented and proprietary photonics technology. Its products are designed to operate at room temperature and low power at an affordable cost. The Company's portfolio of core technologies and products offers capabilities in the areas of high-performance computing, artificial intelligence, and cybersecurity, as well as remote sensing applications.

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Share on Social Networks: